Mukul Prasad

Mukul Prasad

Auto-generated profile, based on publicly available information

Mukul Prasad

Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
MPMukul Prasad
Mukul Prasad
JLJia Le Lin
Jia Le Lin
YGYue Gu
Yue Gu
RGRashi Gupta
Rashi Gupta
PMPaul Macary
Paul Macary
HSHerbert Schwarz
Herbert Schwarz

1 January 2015 in Journal of Natural Science, Biology and Medicine
Verified
Journal Article
Open access
PDF file
SBStephen Charles Bronson
Stephen Charles Bronson
TWTushar Warrier
Tushar Warrier
ABAgnihotram Badarinath
Agnihotram Badarinath
SRShivam Rai
Shivam Rai
KBKaushal Baid
Kaushal Baid
MPMukul Prasad
Mukul Prasad
Background: The increasing incidence of Type 2 diabetes mellitus globally has collaterally increased the incidence of diabetes-associated complications such as neuropathy. Oxidative stress induced DNA damage is one of the mechanisms implicated in the pathogenesis of diabetic complications. Here we aimed to evaluate the extent of DNA damage in diabetes patients with and without clinical neuropathy using the Cytokinesis Block Micronucleus Cytome assay, in a group of South Indian population. Materials and Methods: The Cytokinesis Block Micronucleus Cytome assay was performed in lymphocyte cultures of 42 type 2 diabetes patients (22 with neuropathy and 20 without neuropathy) and 42 age and sex matched controls. Nuclear aberrations like Nuclear Buds, Nucleoplasmic Bridges and Micronuclei were analyzed. Results: The frequency of nuclear aberrations in diabetes patients with neuropathy was higher than compared to diabetes patients without neuropathy. The mean frequencies of nuclear aberrations per cell in diabetes patients with neuropathy and without neuropathy were 0.02 ± 0.02 and 0.01 ± 0.01, respectively. This was significantly higher than in the controls (0.002 ± 0.002) (P < 0.0001). An increasing trend of nuclear aberrations in correlation with the duration of diabetes was observed. Conclusion: This study highlights the use of the Cytokinesis Block Micronucleus Cytome assay as a potent tool for the identification of DNA damage, which may prove to be useful biomarker to assess the severity diabetes-associated complications such as neuropathy. Implementation of this technique at the clinical level would potentially enhance the quality of management of patients with diabetes and its complications like neuropathy.